Novotech

#Novotech and its subsidiary, Novotech Laboratories, participated in the CBA China 2024 Conference in Suzhou, China last week. Dean Tang, Senior Director of Sales Operations & Corporate Strategy for Novotech China, delivered a session titled "Sino-US Early Clinical Strategy and Case Sharing". Our on-site team showcased our clinical trial and laboratory capabilities, engaging attendees with interactive activities. If you missed the opportunity to meet our team, you can connect with us here: https://lnkd.in/drtfdbNZ #CBAChina2024 #ClinicalTrials #Novotech

At Novotech we take pride in supporting your career. We offer development programs, mentorship, and diverse opportunities to help you achieve your career goals. Join us today! Novotech Jobs: https://lnkd.in/gBX4Mmh2 #CRA #clinicaltrials #clinicalresearch #cro #lifeatnovotech

We're thrilled to welcome Dr. Ian Braithwaite as our new Vice President of Global Project Management. Dr. Braithwaite brings exceptional leadership and a strategic clinical background that will be pivotal in advancing our project management efforts. His impressive track record includes senior leadership roles at renowned organizations like Worldwide Clinical Trials, INC Research, and PPD/Thermo Fisher Scientific. Join us in welcoming Dr. Braithwaite to the Novotech family as we continue to expand our global footprint and capabilities to support our biotech clients at every phase. Read more: https://lnkd.in/dRe5EwvG #Novotech #ClinicalOperations #ProjectManagement

#Novotech recently participated in the Round Table event titled "Overview of the Current Landscape of Clinical Trials in Romania," hosted by the Romanian National CRO Association (ACCSCR) and the Avantyo Institute of Clinical Research on June 6, 2024. Our team engaged in discussions focusing on advancements and challenges within Romania's clinical trials industry, demonstrating Novotech’s expertise as a global CRO across all phases. Anca Brasoveanu, Diana Marineanu #ClinicalTrials #CRO #Romania

Novotech successfully participated in the OCT UK & Ireland 2024 event recently in London. Dr. Yooni Kim, Vice President of Clinical Services, Novotech, delivered a compelling session titled "Unlocking APAC's Potential to Enhance Your Clinical Trial Programme.” She highlighted the region’s substantial population and its leadership in adopting digital health technologies. The discussion also highlighted the rapid growth of pharmaceutical sales in the APAC region, driven by market reforms, an expanding middle class, aging populations, and enhanced market access. To gain deeper insights into APAC's potential in clinical trials, explore Dr. Kim's presentation at OCT UK & Ireland 2024 here- https://lnkd.in/dJU4-kMN Yooni Kim, Diana Andreea Filipescu, Alistair Neally, Katie Proctor #Novotech #APAC #ClinicalTrials

Flexibility that fits your life Adjust your start and finish times to create a work schedule that works for you. We empower employees through flexible work arrangements. Follow us to learn more about at - Novotech #lifeatnovotech #cra #clinicaltrials #clinicalresearch #clinicalresearchassociate #cro

#DidYouKnow that there were approximately 2.4 million documented cases of lung cancer globally, with Non-Small Cell Lung Cancer (NSCLC) accounting for 2.1 million cases? Since 2019, more than 5,000 NSCLC clinical trials have been initiated globally. The Asia-Pacific region leads with 41%, followed by North America at 32%, Europe at 19%, and the rest of the world at 8%. This comprehensive report provided by the Novotech analyst team is free of charge. Want to learn more? Download the latest report. https://lnkd.in/dw9C4Fhm #NSCLC #ClinicalResearch #Novotech

Novotech had a successful presence at the DIA 2024 Global Annual Meeting in San Diego, California last week. Our on-site team engaged in insightful discussions, showcasing our expertise as a preferred global CRO across all phases, and highlighting our exceptional workplace qualities. If you missed the opportunity to meet our team, you can connect with us here- https://lnkd.in/drEcqUVD Terra Johnston, Melanie Boyd, Desireé Koerner #DIA2024 #GlobalInnovations #Novotech

The annual ARCS 2024 conference held in Sydney, Australia last week brought together regulatory authorities, government, industry professionals, consumers, patients, practitioners, researchers, and academia to unite, educate, inform and network. Our Director of People Strategy, Aoife McDonnell (Bergin), engaged in thoughtful discussions and contributed to the panel "Building Strong Clinical Trial Teams: Enhancing Efficiency and Cohesion". If you missed the opportunity to engage with our team onsite, you can connect with them here- https://lnkd.in/dpSuUndz #ARCSAnnualConference #WorkplaceExcellence #Novotech

#DidYouKnow that liver cancer ranks as the sixth most diagnosed cancer worldwide, and the third most common cause of cancer death? Over the next 25 years, predictions indicate that liver cancer instances will continue to rise, perhaps exceeding 1.5 million new cases per year by 2050 (a nearly 70% increase since 2022). Download the report on liver cancer to discover the latest advancements in treatment options. https://lnkd.in/dCJr7scb #LiverCancerAwareness #clinicaltrials #Novotech